Article Details

MIVI Neuroscience Presents Primary Endpoint Results from the EvaQ Trial — at the 2024 ...

Retrieved on: 2024-02-09 22:27:18

Tags for this article:

Click the tags to see associated articles and topics

MIVI Neuroscience Presents Primary Endpoint Results from the EvaQ Trial — at the 2024 .... View article details on hiswai:

Excerpt

February 9, 2024 — MIVI Neuroscience, Inc. announced the primary endpoint results of its EvaQ Trial, a prospective, multi-center, global, ...

Article found on: www.dicardiology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo